Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company based in Oxford, U.K. Subject to customary closing conditions, completion of the transaction is expected in the third quarter of this calendar year.
-
-
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear Laboratories’ (CNL) Nuclear Research and Test Establishment Operating License for the Chalk River Laboratories (CRL) site.
-
February 8, 2018 — The U.S. Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC) recently took steps to ensure a stable and secure supply of a critical radioactive imaging tracer used to detect potentially life-threatening diseases.
-
September 9, 2016 — The Alzheimer’s Disease Neuroimaging Initiative (ADNI) recently launched into its next phase, ADNI3, thanks to a $40 million, five-year award from the National Institutes of Health (NIH).
-
September 1, 2016 — The American Society for Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) e-published a new position statement supporting myocardial perfusion...
Potassium Molybdate Mo 99 Source Vessels for RadioGenix System (Photo: Business Wire)
News | Radiopharmaceuticals and Tracers | February 18, 2020
February 18, 2020 — NorthStar Medical Radioisotopes, LLC, a...
Feinstein Institutes' Thomas Chaly, Ph.D., in front of a PET-CT imaging machine. He has been instrumental in pushing for FDA approval of a new PET imaging agent, Fluorodopa F-18 (FDOPA), to combat Parkinson’s
News | Nuclear Imaging | December 26, 2019
December 26, 2019 — The Feinstein Institutes for Medical...
News | Clinical Trials | November 15, 2019
November 15, 2019 — Theragnostics, which is developing innovative...
News | Radiopharmaceuticals and Tracers | October 28, 2019
October 28, 2019 — Phoenix LLC and Shine Medical Technologies LLC, nuclear technology companies focused on near-term...
News | Prostate Cancer | October 16, 2019
October 16, 2019 — GE Healthcare and Theragnostics have entered into a global commercial partnership for a new prostate...
A SPECT nuclear scan of the heart to show perfusion defects in the myocardium due to coronary artery blockages or heart attack. The imaging uses the Mo-99 based medical imaging isotope Tc-99m. The U.S. government has created policy to move away from use of highly enriched uranium (HEU) to low-enriched uranium (LEU) for Mo-99 isotope production, but there is one holdout who has not yet converted before a 2020 deadline. Photo courtesy of Philips Healthcare.
Feature | Nuclear Imaging | August 30, 2019 | Dave Fornell, Editor
In a surprising move, the National Institute for Radioelements (IRE) has applied for a new license to export highly...
Image courtesy of the University of Alabama at Birmingham
News | Radiopharmaceuticals and Tracers | August 29, 2019
August 27, 2019 — The University of Alabama at Birmingham, in conjunction with researchers at the University of...
News | Radiopharmaceuticals and Tracers | August 02, 2019
August 2, 2019 — The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR...
News | Radiopharmaceuticals and Tracers | July 26, 2019
July 26, 2019 — NorthStar Medical Radioisotopes LLC has been awarded $15 million in a cooperative agreement with the U....
News | Radiopharmaceuticals and Tracers | July 16, 2019
July 16, 2019 – NorthStar Medical Radioisotopes LLC announced completion of construction on its 20,000-square-foot...
News | Radiopharmaceuticals and Tracers | July 01, 2019
July 1, 2019 — Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a...
News | Radiopharmaceuticals and Tracers | June 05, 2019
June 5, 2019 – BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel...
Image courtesy of MR Solutions.
News | PET-MRI | May 23, 2019
May 23, 2019 — Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide...
News | Radiopharmaceuticals and Tracers | May 17, 2019
May 17, 2019 — Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b...
News | Radiopharmaceuticals and Tracers | May 13, 2019
May 13, 2019 — Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F))...
Image courtesy of Amen Clinics
News | Radiopharmaceuticals and Tracers | May 10, 2019 | Jeff Zagoudis, Associate Editor
May 10, 2019 — Shine Medical Technologies Inc. broke ground on their first...
Prototype fluidic system for zirconium-89 purification. Image taken through a hot cell window at the Department of Radiology, University of Washington. Image courtesy of Matthew O’Hara, Pacific Northwest National Laboratory
News | Radiopharmaceuticals and Tracers | March 14, 2019
March 14, 2019 — A team of researchers at the University of Washington announced they developed a new automated system...
News | Radiopharmaceuticals and Tracers | January 30, 2019
January 30, 2019 - ImaginAb Inc. announced the enrollment of the first patient in the Phase II...
Technology | Nuclear Imaging | January 16, 2019
January 16, 2019 — MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for...
MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri
News | Radiopharmaceuticals and Tracers | November 13, 2018
November 13, 2018 — The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (...
